MDPI and ACS Style
Song, J.-Y.; Yoon, J.-G.; Seo, Y.-B.; Lee, J.; Eom, J.-S.; Lee, J.-S.; Choi, W.-S.; Lee, E.-Y.; Choi, Y.-A.; Hyun, H.-J.;
et al. Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial. J. Clin. Med. 2021, 10, 3545.
https://doi.org/10.3390/jcm10163545
AMA Style
Song J-Y, Yoon J-G, Seo Y-B, Lee J, Eom J-S, Lee J-S, Choi W-S, Lee E-Y, Choi Y-A, Hyun H-J,
et al. Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial. Journal of Clinical Medicine. 2021; 10(16):3545.
https://doi.org/10.3390/jcm10163545
Chicago/Turabian Style
Song, Joon-Young, Jin-Gu Yoon, Yu-Bin Seo, Jacob Lee, Joong-Sik Eom, Jin-Soo Lee, Won-Suk Choi, Eun-Young Lee, Young-Ah Choi, Hak-Jun Hyun,
and et al. 2021. "Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial" Journal of Clinical Medicine 10, no. 16: 3545.
https://doi.org/10.3390/jcm10163545